These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35945712)

  • 1. Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study.
    Abudoukelimu M; Ba B; Kai Guo Y; Xu J
    Medicine (Baltimore); 2022 Aug; 101(31):e29854. PubMed ID: 35945712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
    Kleber ME; Koller L; Goliasch G; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; März W; Niessner A
    Circ Heart Fail; 2015 Jan; 8(1):25-32. PubMed ID: 25342739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction.
    Albar Z; Albakri M; Hajjari J; Karnib M; Janus SE; Al-Kindi SG
    Am J Cardiol; 2022 Mar; 167():68-75. PubMed ID: 34986991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Biomarkers in Patients With Type 2 Diabetes Mellitus and Heart Failure With Preserved Ejection Faction.
    Sveklina TS; Shustov SB; Kolyubaeva SN; Kuchmin AN; Kozlov VA; Oktysyuk PD; Konyaev VV
    Kardiologiia; 2024 Jul; 64(7):40-47. PubMed ID: 39102572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial perturbation in children and adolescents with type 1 diabetes: association with markers of the inflammatory reaction.
    Romano M; Pomilio M; Vigneri S; Falco A; Chiesa PL; Chiarelli F; Davì G
    Diabetes Care; 2001 Sep; 24(9):1674-8. PubMed ID: 11522718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
    Abernethy A; Raza S; Sun JL; Anstrom KJ; Tracy R; Steiner J; VanBuren P; LeWinter MM
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Serio A; D'Aguanno G; Pinto A; Licata G
    Atherosclerosis; 2010 Nov; 213(1):311-8. PubMed ID: 20889155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of high mobility group box 1, von Willebrand factor and other cytokines in the evaluation of severity and prognosis of sepsis patients].
    Chen Y; Huang X; Kong G; Liu X; Tian H; Lyu B; Ning F; Wang T; Hao D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):933-937. PubMed ID: 32912405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the correlation of insulin resistance and leptin with inflammatory factors and vascular endothelial injury in T2DM patients with CHD.
    Zhang J; Jin J; Liu J; He Y; Zhang P; Ye W; Zhu W; Li M
    Exp Ther Med; 2018 Jul; 16(1):265-269. PubMed ID: 29896248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Reactive Protein, Interleukin-6, Trimethylamine-N-Oxide, Syndecan-1, Nitric Oxide, and Tumor Necrosis Factor Receptor-1 in Heart Failure with Preserved Versus Reduced Ejection Fraction: a Meta-Analysis.
    Gui XY; Rabkin SW
    Curr Heart Fail Rep; 2023 Feb; 20(1):1-11. PubMed ID: 36479675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction.
    Alogna A; Koepp KE; Sabbah M; Espindola Netto JM; Jensen MD; Kirkland JL; Lam CSP; Obokata M; Petrie MC; Ridker PM; Sorimachi H; Tchkonia T; Voors A; Redfield MM; Borlaug BA
    JACC Heart Fail; 2023 Nov; 11(11):1549-1561. PubMed ID: 37565977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
    Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
    Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophils and Circulating Inflammatory Biomarkers in Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction.
    Chaar D; Dumont BL; Vulesevic B; Neagoe PE; Räkel A; White M; Sirois MG
    Am J Cardiol; 2022 Sep; 178():80-88. PubMed ID: 35811144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.
    Zhou XD; Chen QF; Targher G; Byrne CD; Shapiro MD; Tian N; Xiao T; Sung KC; Lip GYH; Zheng MH
    J Am Heart Assoc; 2024 Feb; 13(3):e032997. PubMed ID: 38240197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania.
    Mavrea AM; Dragomir T; Bordejevic DA; Tomescu MC; Ancusa O; Marincu I
    Clin Interv Aging; 2015; 10():979-90. PubMed ID: 26124651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction.
    Yano M; Nishino M; Ukita K; Kawamura A; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Tanaka A; Matsunaga-Lee Y; Egami Y; Shutta R; Tanouchi J; Yamada T; Yasumura Y; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Suna S; Nakatani D; Hikoso S; Sakata Y;
    ESC Heart Fail; 2021 Aug; 8(4):2791-2801. PubMed ID: 33934563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis.
    Chin BS; Conway DS; Chung NA; Blann AD; Gibbs CR; Lip GY
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):515-21. PubMed ID: 12960603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.